AGEN
Agenus Inc

12,535
Mkt Cap
$131.92M
Volume
401,325.00
52W High
$7.34
52W Low
$1.38
PE Ratio
-0.58
AGEN Fundamentals
Price
$4.14
Prev Close
$4.18
Open
$4.24
50D MA
$4.30
Beta
1.98
Avg. Volume
459,492.57
EPS (Annual)
-$10.59
P/B
-0.35
Rev/Employee
$327,414.56
Loading...
Loading...
News
all
press releases
Agenus Reports 39% of Patients Alive at Two-Years with BOT/BAL Across Multiple Refractory Solid Tumors at ESMO 2025
Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced new data from its botensilimab (BOT), a multifunctional, Fc-enhanced CTLA-4 antibody and balstilimab (BAL), a PD-1...
Business Wire·9d ago
News Placeholder
More News
News Placeholder
Agenus to Host October Stakeholder Briefing Showcasing BOT/BAL Global Momentum and Post-ESMO Insights
Agenus Inc. (Agenus) (Nasdaq: AGEN), a leader in immuno-oncology, will host a virtual Stakeholder Briefing on Tuesday, October 21, 2025, at 4:00 p.m. ET. The webcast will feature updates from leading...
Business Wire·10d ago
News Placeholder
Are Options Traders Betting on a Big Move in Agenus tock?
Investors need to pay close attention to AGEN stock based on the movements in the options market lately.
Zacks·1mo ago
News Placeholder
Agenus (AGEN) Reports Q2 Loss, Beats Revenue Estimates
Agenus (AGEN) delivered earnings and revenue surprises of -28.21% and +2.68%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·3mo ago
News Placeholder
Gilead Sciences (GILD) Tops Q2 Earnings and Revenue Estimates
Gilead (GILD) delivered earnings and revenue surprises of +3.08% and +1.95%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·3mo ago
News Placeholder
AnaptysBio, Inc. (ANAB) Reports Q2 Loss, Tops Revenue Estimates
AnaptysBio (ANAB) delivered earnings and revenue surprises of +10.67% and +36.82%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·3mo ago
News Placeholder
Zacks.com featured highlights include QuantumScape, Civeo and Agenus
QuantumScape, Civeo, and Agenus show sharp earnings acceleration, signaling potential upside before Wall Street catches on.
Zacks·3mo ago
News Placeholder
QuantumScape & 2 Other Stocks to Buy for Earnings Acceleration
QS, CVEO, and AGEN show strong earnings acceleration this month - often a signal of stock price momentum ahead.
Zacks·3mo ago
News Placeholder
Is CVS Health (CVS) Stock Outpacing Its Medical Peers This Year?
Here is how CVS Health (CVS) and Agenus (AGEN) have performed compared to their sector so far this year.
Zacks·3mo ago
News Placeholder
VKTX Stock Down on Wider-Than-Expected Loss in Q2, Nil Sales
Shares of Viking slide after Q2 loss widens to 58 cents per share on rising R&D and nil revenues, missing estimates by 14 cents.
Zacks·3mo ago

Latest AGEN News

View

Advertisement|Remove ads.

Advertisement|Remove ads.